Enacts provisions relating to insurance coverage of genetic screenings for cancer risk

HB 2394 requires health insurance plans to cover genetic counseling and specific BRCA1 and BRCA2 genetic testing for individuals at increased risk of breast or ovarian cancer starting in 2025. This coverage must include all associated costs without deductibles or co-pays, provided the testing is recommended by a certified professional following a clinical risk assessment. Additionally, the bill prohibits insurers from using the results of these genetic tests to determine eligibility, set premiums, or make other underwriting decisions. The law applies to all health benefit plans delivered or renewed on or after January 1, 2025, ensuring that preventive care is accessible without financial barriers.